BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10738509)

  • 1. [Lipid derivatives of amphotericin B in treatment of systemic candidiasis].
    Rosenthal E
    Presse Med; 2000 Mar; 29(8):428. PubMed ID: 10738509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
    Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
    [No Abstract]   [Full Text] [Related]  

  • 3. Liposomal amphotericin B in neonates with invasive candidiasis.
    Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
    Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida peritonitis treated with liposomal amphotericin B.
    Ng SY; Morgan M
    Postgrad Med J; 1996 Oct; 72(852):636-7. PubMed ID: 8977956
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of neonatal candidiasis with liposomal amphotericin B.
    Kapoor D
    Indian Pediatr; 2004 May; 41(5):522-3; author reply 523-5. PubMed ID: 15181316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generalised toxicoderma secondary to administering liposomal amphotericin B].
    de Miguel-Bouzas JC; Herrero-Poch L; Piñeiro-Corrales G
    Farm Hosp; 2010; 34(4):211-2. PubMed ID: 20638033
    [No Abstract]   [Full Text] [Related]  

  • 7. Reader clarifies the use of amphotericin B.
    Madej T
    Oncol Nurs Forum; 1998 May; 25(4):653. PubMed ID: 9599340
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal amphotericin B in neonates with invasive candidiasis.
    al Arishi H; Frayha HH; Kalloghlian A; al Alaiyan S
    Am J Perinatol; 1997 Oct; 14(9):573-6. PubMed ID: 9394170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
    Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
    Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP
    Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current candidiasis topics: monitoring Liposomal amphotericin B using candidiasis flow charts (discussion)].
    Takesue Y
    Jpn J Antibiot; 2012 Apr; 65(2):111-9. PubMed ID: 22970634
    [No Abstract]   [Full Text] [Related]  

  • 12. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylactic reaction to liposomal amphotericin B.
    Vaidya SJ; Seydel C; Patel SR; Ortin M
    Ann Pharmacother; 2002 Sep; 36(9):1480-1. PubMed ID: 12196074
    [No Abstract]   [Full Text] [Related]  

  • 14. Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice.
    van Etten EW; Snijders SV; van Vianen W; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2431-3. PubMed ID: 9736577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neonatal candidiasis with liposomal amphotericin B(L-AMP-LRC-1): phase II study.
    Kotwani RN; Bodhe PV; Kirodian BG; Mehta KP; Ali US; Kshirsagar NA
    Indian Pediatr; 2003 Jun; 40(6):545-50. PubMed ID: 12824664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
    Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
    An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature.
    Johnson MD; Drew RH; Perfect JR
    Pharmacotherapy; 1998; 18(5):1053-61. PubMed ID: 9758315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute adverse effects following administration of liposomal amphotericin B].
    Portillo-Cano Mdel M; Lobo-Acosta MA; Ríos-Villegas MJ; Alanís-López J
    Enferm Infecc Microbiol Clin; 2006 May; 24(5):352. PubMed ID: 16762265
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomes as carriers of antifungal drugs.
    Lopez-Berestein G
    Ann N Y Acad Sci; 1988; 544():590-7. PubMed ID: 3214094
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp.
    Dupont B
    Chemotherapy; 1999 Jun; 45 Suppl 1():27-33. PubMed ID: 10394018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.